Most previous studies reported estrogen receptors as a prognostic marker for hormone‐related tumors, such as ESR1 in thyroid carcinoma, and ESR1 and ESR2 in ovarian and breast cancer.9, 11, 12, 44. This evidence concerns the gene ESR1 and thyroid gland carcinoma.